ESC Premium Access

Should we abandon EF to stratify heart failure treatment?

Congress Presentation

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Boston (United States of America)
46 presentations
15 followers

4 more presentations in this session

State of the Art: HFmrEF - The new middle child

Speaker: Professor R. De Boer (Rotterdam, NL)

Thumbnail

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Thumbnail

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Speaker: Doctor M. Gori (Bergamo, IT)

Thumbnail

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Professor S. Solomon, Professor R. De Boer, Doctor G. Savarese, Doctor A. Aimo, Doctor M. Gori
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk